PROGRAM PLANNING AND EVALUATION
PROGRAM PLANNING AND EVALUATION
批准号:
7669890
负责人:
Riccardo Dalla-Favera
金额:
$1.45万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Based on the 2003 NCI review, and in consultation with CUMC and NYPH leadership,- and the newly
constituted External Scientific.Advisory Board, the HICCC Director outlined a Strategic Plan to restructure
and expand the Center.. The Plan included reshaping HICCC Leadership via internal promotions and
recruitments and building active internal and external advisory bodies for the HICCC. This plan was
successfully implemented with the recruitment of the Deputy Director for Clinical Research (Dr. E.
Gelmann), the Associate Director for Biomedical Informatics (Dr. A. Califano), and the internal promotions
of the Associate Director for Basic Research (Dr. R. Baer), the Associate Director for Shared Resources
(Dr. Benjamin Tycko), and the Associate Director for Population Science (Dr. A. Neugut). In addition, three
of the present seven HICCC Programs are led by newly nominated faculty. This reorganization of
leadership has been accompanied by an overhaul of Planning and Evaluation and by the redesign of the
HICCC's internal and external advisory bodies.
The HICCC Director has the responsibility and authority to set priorities and to develop new Programs;
nominate and retain scientific leaders and members; select programs, projects and members to receive
pilot funding; allocate HICCC resources;'and organize the HICCC as a whole to promote productivity and
scientific interactions. The Deputy Director for Clinical Research assists the HICCC Director in
accomplishing these goals and in organizing the HICCC's clinical activities. The Director's decisions are
based on input from the internal and external advisory bodies.
The main internal advisory bodies include: i) the Senior Leadership Team; ii) the Internal Advisory
Committee; iii) the Space Committee; iv) the Membership Committee; . and v) the Shared Resource
Committee.
The External Scientific Advisory Board (ESAB) has been reorganized in its leadership and composition,
currently including 11 members representative of the major areas of HICCC research and administration.
Funding in the amount of $16,500 is requested for the annual meeting of the ESAB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
-
批准号:10737214
-
项目类别:
-
资助金额:$98.7万
-
财政年份:2023
-
负责人:Riccardo Dalla-Favera
-
依托单位:
MSK SPORE in Lymphoma
-
批准号:9753960
-
项目类别:
-
资助金额:$209.4万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:10453790
-
项目类别:
-
资助金额:$94.08万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9528531
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9186876
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9977975
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:10224858
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9326271
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of MEF2B mutations in lymphomagenesis
-
批准号:8697703
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2014
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of MEF2B mutations in lymphomagenesis
-
批准号:8849397
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2014
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8539207
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8643783
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8826085
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8446960
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8627966
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8222362
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Cancer Center Support Grant
-
批准号:7934388
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2009
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Cancer Center Support Grant
-
批准号:7934425
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:Riccardo Dalla-Favera
-
依托单位:
PROGRAM LEADERS
-
批准号:7669884
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2008
-
负责人:Riccardo Dalla-Favera
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:7669891
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2008
-
负责人:Riccardo Dalla-Favera
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: